(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies.

In contrast, nearly all of the differences observed between the controls and sorafenib- or sunitinb-treated samples were highly significant (p<0.001), both in volume and spatial distribution.

also in 132,142 other papers